Veeva Systems Inc. (VEEV) – Can VEEV keep its momentum in long-term?

The company collaborated with ANI Pharmaceuticals to define and operationalize data-driven commercial strategies for the new Rare Disease business unit. The adoption of Veeva Systems applications is expected to provide a significant boost to the Veeva Commercial Cloud product line of its Life Sciences segment.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Developments
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 36